These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8445442)

  • 1. Prevention of symptomatic patent ductus arteriosus with ethamsylate in babies treated with exogenous surfactant.
    Amato M; Hüppi P; Markus D
    J Perinatol; 1993; 13(1):2-7. PubMed ID: 8445442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of patent ductus arteriosus using ethamsylate in preterms treated with exogenous surfactant.
    Amato M; Hüppi PS; Markus D
    Acta Paediatr; 1992 Apr; 81(4):351-2. PubMed ID: 1606398
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.
    Couser RJ; Ferrara TB; Wright GB; Cabalka AK; Schilling CG; Hoekstra RE; Payne NR
    J Pediatr; 1996 May; 128(5 Pt 1):631-7. PubMed ID: 8627434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy.
    Heldt GP; Pesonen E; Merritt TA; Elias W; Sahn DJ
    Pediatr Res; 1989 Mar; 25(3):305-10. PubMed ID: 2649864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of preterm neonates with severe respiratory distress syndrome using exogenous natural surfactants of porcine origin].
    Valls i Soler A; López de Heredia I; Hernaéz Ortega E; Román Echevarría L; Gastiasoro Cuesta E; Robertson B
    An Esp Pediatr; 1992 May; 36(5):375-81. PubMed ID: 1616198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding.
    Rosenfeld W; Sadhev S; Brunot V; Jhaveri R; Zabaleta I; Evans HE
    Pediatrics; 1986 Jul; 78(1):10-4. PubMed ID: 3725477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant substitution in ventilated very low birth weight infants: factors related to response types.
    Segerer H; Stevens P; Schadow B; Maier R; Kattner E; Schwarz H; Curstedt T; Robertson B; Obladen M
    Pediatr Res; 1991 Dec; 30(6):591-6. PubMed ID: 1805156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial.
    Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B
    Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethamsylate in the prevention of patent ductus arteriosus.
    Rosti L; Piva D; Rosti D
    Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1103-4. PubMed ID: 7921106
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome.
    Green TP; Thompson TR; Johnson DE; Lock JE
    N Engl J Med; 1983 Mar; 308(13):743-8. PubMed ID: 6828120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
    Lamboley-Gilmert G; Lacaze-Masmonteil T;
    Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
    Garland J; Buck R; Weinberg M
    Pediatrics; 1994 Nov; 94(5):719-23. PubMed ID: 7936902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
    Clyman RI; Brett C; Mauray F
    Pediatrics; 1980 Nov; 66(5):725-9. PubMed ID: 7432878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.